The effects of rheumatoid arthritis on labor force participation, work performance, and healthcare costs in two workplace samples

Journal of Occupational and Environmental Medicine
Ronald C KesslerPaul Stang

Abstract

To assess the workplace costs of rheumatoid arthritis (RA) from the employer perspective. Samples included 4485 manufacturing firm (MF) employees (109 with RA) and 915 commercially insured (CO) subscribers (333 with RA). Respondents completed the Health and Work Performance Questionnaire (HPQ) and the Health Assessment Questionnaire (HAQ). The effects of RA were estimated using regression analysis. RA was associated with increased probability of no longer working (CO), increased effort to maintain work performance (CO), increased sickness absence (MF), and increased non-RA pharmacy costs (CO). RA was not associated with hours worked or hourly wage. Indirect costs of RA did not exceed direct medical costs. Indirect costs of RA to employers are significant and warrant further research to increase our understanding of the contribution of different RA treatment interventions to optimizing workforce productivity.

References

Feb 1, 1980·Arthritis and Rheumatism·J F FriesH R Holman
May 11, 2000·Seminars in Arthritis and Rheumatism·K M PugnerK Hieke
Apr 5, 2001·Journal of Occupational and Environmental Medicine·R C KesslerP S Wang
Sep 25, 2001·Lancet·D M Lee, M E Weinblatt
Dec 26, 2001·The American Journal of Medicine·T A Loehrl, T L Smith
Jan 5, 2002·Arthritis and Rheumatism·J B WongG Singh
Jul 12, 2002·Arthritis Research·Alan J Silman, Jacqueline E Pearson
Oct 29, 2002·The American Journal of Medicine·John B WongArthur Kavanaugh
Mar 11, 2003·Journal of Occupational and Environmental Medicine·Ronald C KesslerPhillip Wang
Sep 16, 2003·Annals of the Rheumatic Diseases·F GuilleminUNKNOWN Epidemiology Committe of the French Society of Reumatology
Dec 11, 2003·Journal of Occupational and Environmental Medicine·Philip S WangRonald C Kessler
Feb 11, 2004·Joint, Bone, Spine : Revue Du Rhumatisme·Alain SarauxUNKNOWN Epidemiology Section, French Society for Rheumatology
May 1, 2004·Joint, Bone, Spine : Revue Du Rhumatisme·David MalinvaudRémi Marianowski
May 8, 2004·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Dennis A RevickiJan Tack
Jun 15, 2004·Journal of Occupational and Environmental Medicine·Ronald C KesslerT Bedirhan Ustun
Oct 14, 2004·Annals of the Rheumatic Diseases·E M de CroonM H W Frings-Dresen
Nov 5, 2004·PharmacoEconomics·Katherine A Lyseng-Williamson, Greg L Plosker
Dec 14, 2004·Arthritis and Rheumatism·Jasvinder A SinghSiamak Noorbaloochi
Dec 5, 2006·Current Opinion in Rheumatology·Lars KlareskogLars Alfredsson
Jun 15, 2007·Journal of Occupational and Environmental Medicine·F Randy VogenbergDebbie Liebeskind

❮ Previous
Next ❯

Citations

Dec 10, 2013·Best Practice & Research. Clinical Rheumatology·Suzanne M M Verstappen
Jan 20, 2011·Rheumatology·Ivana FilipovicAlistair S Curry
Aug 2, 2015·Joint, Bone, Spine : Revue Du Rhumatisme·Philippe BertinGisela Kobelt
Jan 23, 2016·Rheumatology·Sarah LeggettUNKNOWN at-work productivity global measure working group
Jun 24, 2015·American Journal of Industrial Medicine·Brian W Ward
Dec 23, 2014·Journal of Medical Economics·Michael L GanzMartin Strandberg-Larsen
Sep 10, 2009·The Journal of Rheumatology·Dorcas BeatonPeter S Tugwell
Apr 23, 2010·Psychosomatic Medicine·Joseph A BoscarinoJack Goldberg
Jun 9, 2015·Journal of Occupational and Environmental Medicine·Candace GunnarssonJennifer H Lofland
Jan 10, 2012·Journal of Occupational and Environmental Medicine·W Robert SimonsDigisha N Trivedi
Aug 30, 2012·Journal of Occupational and Environmental Medicine·Harris AllenAhmad B Naim
May 22, 2020·Annals of the American Thoracic Society·Mohmmed AlgamdiChristopher J Ryerson
Jul 10, 2019·Arthritis Care & Research·Yomei ShawTeresa A Simon
Mar 9, 2013·Journal of Occupational and Environmental Medicine·Nathan L KleinmanRichard A Brook
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Howard BirnbaumMary Cifaldi
Aug 10, 2021·Work : a Journal of Prevention, Assessment, and Rehabilitation·Doxa Papakonstantinou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.